Back to Trades
Chakma Justin
InsiderCIK 0001951238
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2025–2026
Chakma Justin has filed 2 SEC reports (2025–2026), all concentrated in ARS Pharmaceuticals, Inc. (SPRY), totaling $4.3M in disclosed volume. Weighing $0 bought versus $1.5M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Jan 5 | SPRY ARS Pharmaceuticals, Inc. | Chakma Justin | Insider | Award | $2.8M |
| Nov 14 | SPRY ARS Pharmaceuticals, Inc. | Chakma Justin | Insider | Sell | $1.5M |
2 filings